1440954-94-8Relevant articles and documents
NOVEL PYRAZOLOPYRIMIDINES
-
Paragraph 0094; 0095, (2013/10/08)
This invention relates to novel pyrazolopyrimidines and their use as metabotropic glutamate 5 receptor antagonists (mGlu5 receptor antagonists), pharmaceutical compositions containing the same, and methods of using the same as agents for treatment or amelioration of mGlu5 receptor mediated disorders.
NOVEL COMPOUNDS
-
Paragraph 0164; 0165; 0166; 0387; 0388; 0389, (2013/06/27)
This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R1, R2, R3 have meanings given in the description.